Lantheus wins FDA approval for TAUKLARIFY™ F-18 tau PET agent
Lantheus (LNTH) announces FDA approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-labeled tau PET imaging agent for Alzheimer’s disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.